Photys Therapeutics and Polymed Biopharmaceuticals Announce the Initiation of aPhase I Clinical Trial of PHT-776/HPB-143, an Oral IRAK4PROTAC Degrader Press Release: August 13, 2026 Read More
Go back to Press Page
